Global MedTech · Innovation & portfolio strategy
Bringing discipline to R&D portfolio and investment decisions
Clarifying how business units and central technology leadership make investment and product-development decisions.
Part of a long-standing client relationship: see all nine workstreams
The challenge
The group needed to prioritise innovation resources across products and business units. Accountability for technical decisions, investment trade-offs and stage-gate progression had to stay clear.
Our approach
- Developed governance options for innovation and technology investment.
- Mapped decision rights between central R&D and business-unit leadership.
- Clarified the portfolio and stage-gate forums.
- Shaped specialist capability options and the innovation narrative for executive stakeholders.
What we delivered
- Investment prioritisation frameworks
- Product governance options and accountability matrices
- Decision-forum charters
- Strategy materials for senior leadership
Client details are anonymised to protect confidentiality.